CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response

Journal of Experimental Medicine

Volumn 210, Issue 8, 2013, Pages 1603-1619

  Martínez Llordella, Marc ^a,c   Esensten, Jonathan H ^a,b   Bailey Bucktrout, Samantha L ^a   Lipsky, Robert H ^d   Marini, Ann ^e   Chen, Jun ^e   Mughal, Mohamed ^f   Mattson, Mark P ^f   Taub, Dennis D ^f   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GEORGE MASON UNIVERSITY   (United States)

^e Uniformed Services University of the Health Sciences   (United States)

^f NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DEC1; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MICROARRAY ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD28; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEINS;

EID: 84884230330     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122387     Document Type: Article

References (70)

1. Acuto, O., and F. Michel. 2003. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat. Rev. Immunol. 3:939-951. http:// dx.doi.org/10.1038/nri1248
2. Acuto, O., S. Mise-Omata, G. Mangino, and F. Michel. 2003. Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. Immunol. Rev. 192:21-31. http://dx.doi .org/10.1034/j.1600-065X.2003.00034.x
3. Amyes, E., A.J. McMichael, and M.F. Callan. 2005. Human CD4+ T cells are predominantly distributed among six phenotypically and functionally distinct subsets. J. Immunol. 175:5765-5773.
4. Binder, M., F.N. Vögtle, S. Michelfelder, F. Müller, G. Illerhaus, S. Sundararajan, R. Mertelsmann, and M. Trepel. 2007. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab. Cancer Res. 67:3518- 3523. http://dx.doi.org/10.1158/0008-5472.CAN-06-3919
5. Boise, L.H., A.J. Minn, P.J. Noel, C.H. June, M.A. Accavitti, T. Lindsten, and C.B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:87-98. http:// dx.doi.org/10.1016/1074-7613(95)90161-2
6. Boudjelal, M., R. Taneja, S. Matsubara, P. Bouillet, P. Dolle, and P. Chambon. 1997. Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev. 11:2052-2065. http://dx.doi.org/10.1101/gad.11.16.2052
7. Bour-Jordan, H., B.L. Salomon, H.L. Thompson, G.L. Szot, M.R. Bernhard, and J.A. Bluestone. 2004. Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J. Clin. Invest. 114:979-987.
8. Bour-Jordan, H., J.H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J.A. Bluestone. 2011. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 241:180-205. http://dx.doi.org/10.1111/j.1600- 065X.2011.01011.x
9. Boyman, O., M. Kovar, M.P. Rubinstein, C.D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 311:1924-1927. http://dx.doi.org/10.1126/science.1122927
10. Butte, M.J., S.J. Lee, J. Jesneck, M.E. Keir, W.N. Haining, and A.H. Sharpe. 2012. CD28 costimulation regulates genome-wide effects on alternative splicing. PLoS ONE. 7:e40032. http://dx.doi.org/10.1371/journal .pone.0040032
11. Chakrabarti, J., H. Turley, L. Campo, C. Han, A.L. Harris, K.C. Gatter, and S.B. Fox. 2004. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br. J. Cancer. 91:954-958. http://dx.doi.org/10.1038/sj.bjc.6602059
12. Chu, C.Q., S. Wittmer, and D.K. Dalton. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:123-128. http://dx.doi.org/10.1084/jem.192.1.123
13. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12:560-567. http:// dx.doi.org/10.1038/ni.2027
14. Diehn, M., A.A. Alizadeh, O.J. Rando, C.L. Liu, K. Stankunas, D. Botstein, G.R. Crabtree, and P.O. Brown. 2002. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA. 99:11796-11801. http://dx.doi.org/ 10.1073/pnas.092284399
15. Dooms, H., and A.K. Abbas. 2006. Control of CD4+ T-cell memory by cytokines and costimulators. Immunol. Rev. 211:23-38. http://dx.doi .org/10.1111/j.0105-2896.2006.00387.x
16. Ellisen, L.W., R.E. Palmer, R.G. Maki, V.B. Truong, P. Tamayo, J.D. Oliner, and D.A. Haber. 2001. Cascades of transcriptional induction during human lymphocyte activation. Eur. J. Cell Biol. 80:321-328. http://dx.doi .org/10.1078/0171-9335-00162
17. Esensten, J.H., M.R. Lee, L.H. Glimcher, and J.A. Bluestone. 2009. T-betdeficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J. Immunol. 183:75-82. http:// dx.doi.org/10.4049/jimmunol.0804154
18. Haak, S., A.L. Croxford, K. Kreymborg, F.L. Heppner, S. Pouly, B. Becher, and A. Waisman. 2009. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119:61-69.
19. Honma, S., T. Kawamoto, Y. Takagi, K. Fujimoto, F. Sato, M. Noshiro, Y. Kato, and K. Honma. 2002. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 419:841-844. http://dx.doi.org/ 10.1038/nature01123
20. Iizuka, K., and Y. Horikawa. 2008. Regulation of lipogenesis via BHLHB2/ DEC1 and ChREBP feedback looping. Biochem. Biophys. Res. Commun. 374:95-100. http://dx.doi.org/10.1016/j.bbrc.2008.06.101
21. Ivanova, A., S.Y. Liao, M.I. Lerman, S. Ivanov, and E.J. Stanbridge. 2005. STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker. J. Med. Genet. 42:565-576. http://dx.doi.org/10.1136/jmg.2004.029835
22. Jain, J., P.G. McCaffrey, Z. Miner, T.K. Kerppola, J.N. Lambert, G.L. Verdine, T. Curran, and A. Rao. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 365:352- 355. http://dx.doi.org/10.1038/365352a0
23. Jiang, X., F. Tian, Y. Du, N.G. Copeland, N.A. Jenkins, L. Tessarollo, X. Wu, H. Pan, X.Z. Hu, K. Xu, et al. 2008. BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability. J. Neurosci. 28:1118-1130. http://dx.doi.org/10.1523/JNEUROSCI.2262-07.2008
24. Jin, P., E. Wang, M. Provenzano, S. Deola, S. Selleri, J. Ren, S. Voiculescu, D. Stroncek, M.C. Panelli, and F.M. Marincola. 2006. Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets. J. Transl. Med. 4:26. http://dx.doi.org/10.1186/1479-5876-4-26
25. Kempiak, S.J., T.S. Hiura, and A.E. Nel. 1999. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: proof of cross-talk with the I kappa B kinase cascade. J. Immunol. 162:3176-3187.
26. Kon, N., T. Hirota, T. Kawamoto, Y. Kato, T. Tsubota, and Y. Fukada. 2008. Activation of TGF-beta/activin signalling resets the circadian clock through rapid induction of Dec1 transcripts. Nat. Cell Biol. 10:1463- 1469. http://dx.doi.org/10.1038/ncb1806
27. Köntgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin- 2 expression. Genes Dev. 9:1965-1977. http://dx.doi.org/10.1101/ gad.9.16.1965
28. Ledbetter, J.A., J.B. Imboden, G.L. Schieven, L.S. Grosmaire, P.S. Rabinovitch, T. Lindsten, C.B. Thompson, and C.H. June. 1990. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood. 75:1531-1539.
29. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258. http://dx.doi .org/10.1146/annurev.immunol.14.1.233
30. Li, Y., H. Zhang, M. Xie, M. Hu, S. Ge, D. Yang, Y. Wan, and B. Yan. 2002. Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem. J. 367:413-422. http://dx.doi .org/10.1042/BJ20020514
31. Li, Y., M. Xie, X. Song, S. Gragen, K. Sachdeva, Y. Wan, and B. Yan. 2003. DEC1 negatively regulates the expression of DEC2 through binding to the E-box in the proximal promoter. J. Biol. Chem. 278:16899-16907. http://dx.doi.org/10.1074/jbc.M300596200
32. Li, Y., M. Xie, J. Yang, D. Yang, R. Deng, Y. Wan, and B. Yan. 2006. The expression of antiapoptotic protein survivin is transcriptionally upregulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter. Oncogene. 25:3296-3306. http://dx.doi.org/10.1038/sj.onc .1209363
33. Linsley, P.S., and S.G. Nadler. 2009. The clinical utility of inhibiting CD28- mediated costimulation. Immunol. Rev. 229:307-321. http://dx.doi .org/10.1111/j.1600-065X.2009.00780.x
34. Liu, Z., Z. Li, K. Mao, J. Zou, Y. Wang, Z. Tao, G. Lin, L. Tian, Y. Ji, X. Wu, et al. 2009. Dec2 promotes Th2 cell differentiation by enhancing IL-2R signaling. J. Immunol. 183:6320-6329. http://dx.doi .org/10.4049/jimmunol.0900975
35. Lohr, J., B. Knoechel, and A.K. Abbas. 2006. Regulatory T cells in the periphery. Immunol. Rev. 212:149-162. http://dx.doi.org/10.1111/ j.0105-2896.2006.00414.x
36. Macián, F., F. García-Cózar, S.H. Im, H.F. Horton, M.C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell. 109:719-731. http://dx.doi.org/10.1016/S0092-8674(02)00767-5
37. Marinari, B., A. Costanzo, V. Marzano, E. Piccolella, and L. Tuosto. 2004. CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters. Proc. Natl. Acad. Sci. USA. 101:6098-6103. http://dx.doi.org/ 10.1073/pnas.0308688101
38. McQualter, J.L., R. Darwiche, C. Ewing, M. Onuki, T.W. Kay, J.A. Hamilton, H.H. Reid, and C.C. Bernard. 2001. Granulocyte macrophage colonystimulating factor: A new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194:873-882. http://dx.doi.org/10.1084/jem.194.7.873
39. Miyazaki, K., T. Kawamoto, K. Tanimoto, M. Nishiyama, H. Honda, and Y. Kato. 2002. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J. Biol. Chem. 277:47014-47021. http://dx.doi.org/10.1074/jbc.M204938200
40. Miyazaki, K., M. Miyazaki, Y. Guo, N. Yamasaki, M. Kanno, Z. Honda, H. Oda, H. Kawamoto, and H. Honda. 2010. The role of the basic helixloop- helix transcription factor Dec1 in the regulatory T cells. J. Immunol. 185:7330-7339. http://dx.doi.org/10.4049/jimmunol.1001381
41. Moon, J.J., H.H. Chu, J. Hataye, A.J. Pagán, M. Pepper, J.B. McLachlan, T. Zell, and M.K. Jenkins. 2009. Tracking epitope-specific T cells. Nat. Protoc. 4:565-581. http://dx.doi.org/10.1038/nprot.2009.9
42. Noel, P.J., L.H. Boise, J.M. Green, and C.B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636-642.
43. Oliveira-dos-Santos, A.J., A. Ho, Y. Tada, J.J. Lafaille, S. Tonegawa, T.W. Mak, and J.M. Penninger. 1999. CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis. J. Immunol. 162:4490-4495.
44. Park, S.G., J. Schulze-Luehrman, M.S. Hayden, N. Hashimoto, W. Ogawa, M. Kasuga, and S. Ghosh. 2009. The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells. Nat. Immunol. 10:158-166. http://dx.doi.org/10.1038/ ni.1687
45. Perrin, P.J., D. Scott, L. Quigley, P.S. Albert, O. Feder, G.S. Gray, R. Abe, C.H. June, and M.K. Racke. 1995. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J. Immunol. 154:1481-1490.
46. Perrin, P.J., C.H. June, J.H. Maldonado, R.B. Ratts, and M.K. Racke. 1999. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 163:1704-1710.
47. Petermann, F., and T. Korn. 2011. Cytokines and effector T cell subsets causing autoimmune CNS disease. FEBS Lett. 585:3747-3757. http:// dx.doi.org/10.1016/j.febslet.2011.03.064
48. Ponomarev, E.D., L.P. Shriver, K. Maresz, J. Pedras-Vasconcelos, D. Verthelyi, and B.N. Dittel. 2007. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178:39-48.
49. Putnam, A.L., T.M. Brusko, M.R. Lee, W. Liu, G.L. Szot, T. Ghosh, M.A. Atkinson, and J.A. Bluestone. 2009. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes. 58:652-662. http://dx.doi .org/10.2337/db08-1168
50. Radich, J.P., M. Mao, S. Stepaniants, M. Biery, J. Castle, T. Ward, G. Schimmack, S. Kobayashi, M. Carleton, J. Lampe, and P.S. Linsley. 2004. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics. 83:980-988. http://dx.doi.org/10.1016/ j.ygeno.2003.12.013
51. Rao, S., S. Gerondakis, D. Woltring, and M.F. Shannon. 2003. c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J. Immunol. 170:3724-3731.
52. Riley, J.L., M. Mao, S. Kobayashi, M. Biery, J. Burchard, G. Cavet, B.P. Gregson, C.H. June, and P.S. Linsley. 2002. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc. Natl. Acad. Sci. USA. 99:11790-11795. http://dx.doi.org/10.1073/ pnas.162359999
53. Robertson, M.J., K.J. Cochran, C. Cameron, J.M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24:406-415.
54. Rossner, M.J., H. Oster, S.P. Wichert, L. Reinecke, M.C. Wehr, J. Reinecke, G. Eichele, R. Taneja, and K.A. Nave. 2008. Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice. PLoS ONE. 3:e2762. http://dx.doi.org/10.1371/journal.pone.0002762
55. Salomon, B., D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone. 2000. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:431-440. http://dx.doi.org/ 10.1016/S1074-7613(00)80195-8
56. Sanchez-Lockhart, M., E. Marin, B. Graf, R. Abe, Y. Harada, C.E. Sedwick, and J. Miller. 2004. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J. Immunol. 173:7120-7124.
57. Sánchez-Valdepeñas, C., A.G. Martín, P. Ramakrishnan, D. Wallach, and M. Fresno. 2006. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity. J. Immunol. 176:4666-4674.
58. Schwartz, R.H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305-334. http:// dx.doi.org/10.1146/annurev.immunol.21.120601.141110
59. Sharpe, A.H., and G.J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-126. http://dx.doi.org/10.1038/nri727
60. Sun, H., B. Lu, R.Q. Li, R.A. Flavell, and R. Taneja. 2001. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2:1040-1047. http://dx.doi.org/10.1038/ni721
61. Takeda, K., Y. Harada, R. Watanabe, Y. Inutake, S. Ogawa, K. Onuki, S. Kagaya, K. Tanabe, H. Kishimoto, and R. Abe. 2008. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/ Gads axis. Int. Immunol. 20:1507-1515. http://dx.doi.org/10.1093/ intimm/dxn108
62. Tullai, J.W., M.E. Schaffer, S. Mullenbrock, S. Kasif, and G.M. Cooper. 2004. Identification of transcription factor binding sites upstream of human genes regulated by the phosphatidylinositol 3-kinase and MEK/ERK signaling pathways. J. Biol. Chem. 279:20167-20177. http://dx.doi.org/ 10.1074/jbc.M309260200
63. Wakamatsu, E., D. Mathis, and C. Benoist. 2013. Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells. Proc. Natl. Acad. Sci. USA. 110:1023-1028. http://dx.doi.org/ 10.1073/pnas.1220688110
64. Wang, R., C.P. Dillon, L.Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L.L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D.R. Green. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 35:871-882. http://dx.doi .org/10.1016/j.immuni.2011.09.021
65. Wang, R., H. Xie, Z. Huang, W. Shang, and Z. Sun. 2012. Developing and activated T cell survival depends on differential signaling pathways to regulate anti-apoptotic Bcl-x(L). Clin. Dev. Immunol. 2012:632837.
66. Wang, W., C. Reiser-Erkan, C.W. Michalski, M.C. Raggi, L. Quan, Z. Yupei, H. Friess, M. Erkan, and J. Kleeff. 2010. Hypoxia inducible BHLHB2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Biochem. Biophys. Res. Commun. 401:422-428. http://dx.doi.org/10.1016/j.bbrc.2010.09.070
67. Webster, K.E., S. Walters, R.E. Kohler, T. Mrkvan, O. Boyman, C.D. Surh, S.T. Grey, and J. Sprent. 2009. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206:751-760. http://dx.doi.org/10.1084/jem.20082824
68. Whitney, A.R., M. Diehn, S.J. Popper, A.A. Alizadeh, J.C. Boldrick, D.A. Relman, and P.O. Brown. 2003. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. USA. 100:1896- 1901. http://dx.doi.org/10.1073/pnas.252784499
69. Yang, X.O., P. Angkasekwinai, J. Zhu, J. Peng, Z. Liu, R. Nurieva, X. Liu, Y. Chung, S.H. Chang, B. Sun, and C. Dong. 2009. Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment. Nat. Immunol. 10:1260-1266. http://dx.doi.org/10.1038/ni.1821
70. Zheng, Y., Y. Jia, Y. Wang, M. Wang, B. Li, X. Shi, X. Ma, D. Xiao, and Y. Sun. 2009. The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer. OMICS. 13:301-306. http://dx.doi.org/10.1089/omi.2009.0014